Establishment of Center for Diagnostic Nanosystems
Abstract
Funding from this project was used to develop several “mini-cores” that contained shared equipment that could be used by researchers at Marshall University. Equipment purchased during this project included: a fluorescencent microplate reader, FTIR system, UV-Vis spectrophotometer, and DNA/RNA analyzer. Other deliverables included the funding of several graduate and undergraduate students, postdoctoral fellows and two research assistant professors. Projects supported by this funding included studies performed at the whole animal, organ, cellular and nano level. Several different types of researchers were supported including undergraduates, graduates, postdoctoral fellows and research assistant professors. The main outcomes of this work was the development of new types of nanoparticles that could be used for the treatment of pulmonary arterial hypertension and sepsis. Additional efforts to develop these projects are ongoing.
Read the paper
Related studies
- Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol
- Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
- SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism
- Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors
- Sodium-glucose cotransporter inhibitors: beyond glycaemic control
- Decoding the effects of SGLT2 inhibitors on cardiac arrhythmias in heart failure
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.